DB:L2T1

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. More Details

Rewards

Trading at 72.3% below our estimate of its fair value

Earnings grew by 47.2% over the past year

Risk Analysis

No risks detected for L2T1 from our risk checks.


Snowflake Analysis

Flawless balance sheet with outstanding track record.


Similar Companies

Share Price & News

How has LifeVantage's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: L2T1 is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: L2T1's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

-0.5%

L2T1

-4.8%

DE Personal Products

0.7%

DE Market


1 Year Return

-30.6%

L2T1

1.8%

DE Personal Products

0.6%

DE Market

Return vs Industry: L2T1 underperformed the German Personal Products industry which returned 1.8% over the past year.

Return vs Market: L2T1 underperformed the German Market which returned 0.6% over the past year.


Shareholder returns

L2T1IndustryMarket
7 Day-0.5%-4.8%0.7%
30 Day-6.1%-0.3%7.8%
90 Day-24.4%1.2%1.7%
1 Year-30.6%-30.6%4.0%1.8%3.9%0.6%
3 Year108.1%108.1%31.2%22.3%4.0%-5.0%
5 Year19.6%19.6%56.1%39.0%21.4%4.2%

Long-Term Price Volatility Vs. Market

How volatile is LifeVantage's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is LifeVantage undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: L2T1 (€9.3) is trading below our estimate of fair value (€33.6)

Significantly Below Fair Value: L2T1 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: L2T1 is good value based on its PE Ratio (12.9x) compared to the XE Personal Products industry average (20.8x).

PE vs Market: L2T1 is good value based on its PE Ratio (12.9x) compared to the German market (23.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate L2T1's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: L2T1 is overvalued based on its PB Ratio (4.7x) compared to the XE Personal Products industry average (2.4x).


Next Steps

Future Growth

How is LifeVantage forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

9.6%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LifeVantage has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has LifeVantage performed over the past 5 years?

28.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: L2T1 has high quality earnings.

Growing Profit Margin: L2T1's current net profit margins (5.3%) are higher than last year (3.7%).


Past Earnings Growth Analysis

Earnings Trend: L2T1's earnings have grown significantly by 28.2% per year over the past 5 years.

Accelerating Growth: L2T1's earnings growth over the past year (47.2%) exceeds its 5-year average (28.2% per year).

Earnings vs Industry: L2T1 earnings growth over the past year (47.2%) exceeded the Personal Products industry 16.3%.


Return on Equity

High ROE: L2T1's Return on Equity (35.9%) is considered high.


Next Steps

Financial Health

How is LifeVantage's financial position?


Financial Position Analysis

Short Term Liabilities: L2T1's short term assets ($41.0M) exceed its short term liabilities ($22.0M).

Long Term Liabilities: L2T1's short term assets ($41.0M) exceed its long term liabilities ($14.1M).


Debt to Equity History and Analysis

Debt Level: L2T1 is debt free.

Reducing Debt: L2T1 has no debt compared to 5 years ago when its debt to equity ratio was 360%.

Debt Coverage: L2T1 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: L2T1 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is LifeVantage current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate L2T1's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate L2T1's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if L2T1's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if L2T1's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of L2T1's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Steve Fife (59 yo)

0.17

Tenure

US$1,068,904

Compensation

Mr. Steven R. Fife, also known as Steve, has been the Chief Financial Officer of Lifevantage Corporation since March 13, 2017 and also serves as its Interim President and Chief Executive Officer since Sept...


CEO Compensation Analysis

Compensation vs Market: Steve's total compensation ($USD1.07M) is above average for companies of similar size in the German market ($USD692.51K).

Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Steven Fife
Interim President0.17yrUS$1.07m0.60%
$ 794.3k
Kevin McMurray
General Counsel3.17yrsUS$678.14k0.27%
$ 361.2k
Justin Rose
Chief Sales & Marketing Officer5.33yrsUS$734.55k0.87%
$ 1.2m
Charles Wach
Chief Operating Officer3.67yrsUS$572.31k0.15%
$ 203.1k
Eric Marchant
Vice President of Complianceno datano datano data
Chris Taylor
Director of Communicationsno datano datano data
Michelle Oborn-Virchow
Senior Vice President of Human Resources5yrsUS$627.21kno data
Dave Fleming
Senior Vice President of Global Field Development4.33yrsno datano data
Brian Dixon
Senior Vice President of Research & Development1.33yrsno datano data
Eiichi Shiokawa
Managing Director - Japanno datano datano data

3.7yrs

Average Tenure

58yo

Average Age

Experienced Management: L2T1's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Michael Beindorff
Independent Director8.83yrsUS$142.78k0.53%
$ 704.0k
Raymond Greer
Independent Director3.75yrsUS$136.78k0.36%
$ 486.2k
Darwin Lewis
Independent Director3.75yrsUS$142.78k0.38%
$ 505.0k
Garry Mauro
Independent Chairman7yrsUS$148.78k1%
$ 1.3m
Vinayak Hegde
Independent Director3.75yrsUS$136.78k0.35%
$ 472.2k
Erin Brockovich
Independent Director1.5yrsUS$136.78k0.060%
$ 80.2k

3.8yrs

Average Tenure

60.5yo

Average Age

Experienced Board: L2T1's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

LifeVantage Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: LifeVantage Corporation
  • Ticker: L2T1
  • Exchange: DB
  • Founded:
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$158.938m
  • Listing Market Cap: US$133.492m
  • Shares outstanding: 14.24m
  • Website: https://www.lifevantage.com

Number of Employees


Location

  • LifeVantage Corporation
  • 9785 South Monroe Street
  • Suite 400
  • Sandy
  • Utah
  • 84070
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LFVNNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDOct 2004
L2T1DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2004

Biography

LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/26 19:30
End of Day Share Price2020/11/25 00:00
Earnings2020/09/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.